Poster Presentation at the 2026 Crohn's & Colitis Congress® Showcases Use of Causal Machine Learning and IBD Plexus® to Optimize Trial Execution BOSTON, Jan. 22, 2026 /PRNewswire/ -- PhaseV, a leader in AI/ML for clinical development, is today presenting new study results demonstrating...
Hence then, the article about phasev demonstrates how ai driven site selection and real time analytics reduce recruitment uncertainty and accelerate ibd clinical trials was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( PhaseV Demonstrates How AI-Driven Site Selection and Real-Time Analytics Reduce Recruitment Uncertainty and Accelerate IBD Clinical Trials )
Also on site :
- 'Love on the Spectrum' Star Hard Launches New Romance — And Fans Are Shocked by One Trait
- Who Won ‘Jeopardy’ Today? (July 6, 2026) Plus, the Final Jeopardy Answer
- Walmart’s Fan-Favorite Zero-Gravity Canopy Lounge Chair Is 50% Off and ‘Perfect for Bird Watching and Stargazing’